Abstract
Isolated human colonic epithelial cell suspensions were incubated with either 0.1 mM 5-aminosalicylic acid (5-ASA) or 0.1 mM acetylaminosalicylic acid (Ac-ASA) for up to two hours. Intra- and extracellular 5-ASA and Ac-ASA were measured by high performance liquid chromatography. Mean 5-ASA uptake in one hour was 160.5 nmol/g dry weight, compared with an Ac-ASA uptake of only 5.75 nmol/g dry weight. No unchanged 5-ASA was detected inside the cell. Repeated washing had no effect on the intracellular Ac-ASA concentration. This discrepancy in drug uptake may explain why Ac-ASA seems to be ineffective when given to patients with ulcerative colitis.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allgayer H., Stenson W. F. A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid. Immunopharmacology. 1988 Jan-Feb;15(1):39–46. doi: 10.1016/0162-3109(88)90041-0. [DOI] [PubMed] [Google Scholar]
- Azad Khan A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977 Oct 29;2(8044):892–895. doi: 10.1016/s0140-6736(77)90831-5. [DOI] [PubMed] [Google Scholar]
- Bondesen S., Nielsen O. H., Schou J. B., Jensen P. H., Lassen L. B., Binder V., Krasilnikoff P. A., Danø P., Hansen S. H., Rasmussen S. N. Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis. Scand J Gastroenterol. 1986 Aug;21(6):693–700. doi: 10.3109/00365528609011102. [DOI] [PubMed] [Google Scholar]
- Ireland A., Priddle J. D., Jewell D. P. Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells. Clin Sci (Lond) 1990 Jan;78(1):105–111. doi: 10.1042/cs0780105. [DOI] [PubMed] [Google Scholar]
- Lauritsen K., Hansen J., Ryde M., Rask-Madsen J. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology. 1984 Jun;86(6):1496–1500. [PubMed] [Google Scholar]
- Meese C. O., Fischer C., Klotz U. Is N-acetylation of 5-aminosalicylic acid reversible in man? Br J Clin Pharmacol. 1984 Oct;18(4):612–615. doi: 10.1111/j.1365-2125.1984.tb02513.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roediger W. E., Truelove S. C. Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979 Jun;20(6):484–488. doi: 10.1136/gut.20.6.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Willoughby C. P., Piris J., Truelove S. C. The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol. 1980;15(6):715–719. doi: 10.3109/00365528009181520. [DOI] [PubMed] [Google Scholar]
- Yasuhara M., Kurosaki Y., Kimura T., Sezaki H. Drug elimination function of rat small intestine: metabolism and intraluminal excretion. Biochem Pharmacol. 1984 Oct 15;33(20):3131–3136. doi: 10.1016/0006-2952(84)90068-6. [DOI] [PubMed] [Google Scholar]
- van Hees P. A., Bakker J. H., van Tongeren J. H. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. Gut. 1980 Jul;21(7):632–635. doi: 10.1136/gut.21.7.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Hogezand R. A. Pharmacokinetics of olsalazine and its metabolites. Scand J Gastroenterol Suppl. 1988;148:17–20. doi: 10.3109/00365528809101541. [DOI] [PubMed] [Google Scholar]
- van Hogezand R. A., van Hees P. A., van Gorp J. P., van Lier H. J., Bakker J. H., Wesseling P., van Haelst U. J., van Tongeren J. H. Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis. Aliment Pharmacol Ther. 1988 Feb;2(1):33–40. doi: 10.1111/j.1365-2036.1988.tb00668.x. [DOI] [PubMed] [Google Scholar]